Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Leases (2019 - 2025)

Abeona Therapeutics (ABEO) has 7 years of Leases data on record, last reported at $4.1 million in Q3 2025.

  • For Q3 2025, Leases rose 7.84% year-over-year to $4.1 million; the TTM value through Sep 2025 reached $4.1 million, up 7.84%, while the annual FY2024 figure was $3.6 million, 20.27% down from the prior year.
  • Leases reached $4.1 million in Q3 2025 per ABEO's latest filing, down from $4.1 million in the prior quarter.
  • Across five years, Leases topped out at $9.4 million in Q4 2021 and bottomed at $3.6 million in Q4 2024.
  • Average Leases over 5 years is $5.4 million, with a median of $4.9 million recorded in 2023.
  • Peak YoY movement for Leases: soared 33.72% in 2021, then plummeted 43.31% in 2022.
  • A 5-year view of Leases shows it stood at $9.4 million in 2021, then tumbled by 43.31% to $5.3 million in 2022, then decreased by 16.43% to $4.5 million in 2023, then fell by 20.27% to $3.6 million in 2024, then increased by 15.03% to $4.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $4.1 million in Q3 2025, $4.1 million in Q2 2025, and $4.2 million in Q1 2025.